BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Embryo
,
Laryngoscope
,
Valproic acid
,
rs7903146
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
secreting pituitary tumors
Summary
General Info
Curated Studies
Most Correlated Studies
Adipose tissues from Cushing's disease or non-functioning pituitary adenoma patients
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Pituitary gonadotrope and null cell tumor expression profiling
Explore Curated Studies Results
Literature
Most Relevant Literature
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone s…
Syndromes of resistance to thyroid hormone and inappropriate secretion of TSH (SITSH)].
Atypical pituitary tumors].
Aip regulates cAMP signalling and GH secretion in GH3 cells.
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endo…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Dise…
The Observational Study of Growth Hormone-secreting Pituitary Tumors
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Characterization of Receptors in Non-functioning Pituitary Macroadenomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ